pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
Fierce Biotech·17h ago·1 min read
save

Scientists boycott American Diabetes Association after conference expulsions

Sep 10, 2026·read at Fierce Biotech ↗Negative

Following the removal of five scientists from its annual conference in June, members of the American Diabetes Association (ADA) have initiated a boycott of the organization. The protest stems from what participants describe as an unjust expulsion of the researchers during the meeting.

The boycott letter, released on September 9, pledges to halt the review of grants and new articles submitted to the ADA’s flagship journal, Diabetes Care, and to refrain from attending any meetings led by ADA leadership or the board. Hundreds of scientists have signed the open letter, demanding changes in the association’s leadership.

The ADA acknowledged the boycott in a statement, thanking professionals who continue to support its mission and emphasizing its focus on serving the diabetes community. The organization did not comment on any specific actions it might take in response to the boycott.

source

This writeup was produced by pharmadog from original reporting by Fierce Biotech.

Original headline: “Scientists boycott American Diabetes Association as fallout of June conference fracas escalates”

read at Fierce Biotech ↗
739 words · retrieved 1h ago
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
University of Washington
topics
Type 2 Diabetes19CardiologyEndocrinology & MetabolismGLP-1 receptor

related stories

  • 1d agoWebinar: The Massive Scale of GLP-1s: Evolving Health, Healthcare and MarketsBioSpace
  • Sep 2Beyond GLP‑1s: The race for next‑gen obesity drugs starts in the preclinical modelsBioSpace
  • Aug 28Lilly joins Novo in cardiovascular space after FDA nod for GLP-1/GIP agonist MounjaroBioSpace
  • Aug 26On the fence about a statin? In borderline cases, calcium scans could be a tiebreakerSTAT
  • Aug 24Roche pens $2.5B pact for Hanmi’s clinical-stage obesity drug targeting less-explored mechanismFierce Biotech